US2016009652A1PendingUtilityA1
Small-molecule modulators of melanin expression
Est. expiryMar 30, 2027(~0.7 yrs left)· nominal 20-yr term from priority
A61Q 17/04A61K 8/4926C07D 215/54A61K 8/4973A61Q 19/04A61K 8/69C07D 307/68A61K 8/4953C07D 405/06C07D 261/18C07D 211/14
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to small molecule modulators of melanin expression and methods of making the small molecules. Also disclosed are methods of increasing pigmentation in a cell which involve providing compounds of the present invention and contacting a cell with the compounds under conditions effective to induce melanin expression in the cell, thereby increasing pigmentation. The present invention also relates to compositions containing compounds of the present invention and a carrier.
Claims
exact text as granted — not AI-modified1 . A compound formed by a reaction of a carboxylic acid and an amine, wherein the carboxylic acid is selected from:
and the amine is selected from:
2 . The compound according to claim 1 , wherein the compound is selected from the group of N-(4-fluorophenethyl)-2-ethylquinoline-3-carboxamide; N-(3-fluorophenethyl)-2-ethylquinoline-3-carboxamide; N-((furan-2-yl)methyl)furan-2-carboxamide; N-butylfuran-2-carboxamide; N-(4-fluorophenethyl)furan-2-carboxamide; N-(3-fluorophenethyl)furan-2-carboxamide; (furan-2-yl)(2,2,6,6-tetramethylpiperidin-1-yl)methanone; (2,2,6,6-tetramethylpiperidin-1-yl)(perfluorophenyl)methanone; 2,3,4,5,6-pentafluoro-N-(5-methylisoxazol-3-yl)benzamide; and (benzo [d][1,3]dioxol-5-yl)(4-(4-fluorophenyl)piperazin-1-yl)methanone.
3 . A method of increasing pigmentation in a cell, said method comprising:
providing a compound according to claim 1 and contacting a cell with the compound under conditions effective to induce melanin expression in the cell, thereby increasing pigmentation.
4 . The method according to claim 3 , wherein the compound is selected from the group of N-(4-fluorophenethyl)-2-ethylquinoline-3-carboxamide; N-(3-fluorophenethyl)-2-ethylquinoline-3-carboxamide; N-((furan-2-yl)methyl)furan-2-carboxamide; N-butylfuran-2-carboxamide; N-(4-fluorophenethyl)furan-2-carboxamide; N-(3-fluorophenethyl)furan-2-carboxamide; (furan-2-yl)(2,2,6,6-tetramethylpiperidin-1-yl)methanone; (2,2,6,6-tetramethylpiperidin-1-yl)(perfluorophenyl)methanone; 2,3,4,5,6-pentafluoro-N-(5-methylisoxazol-3-yl)benzamide; and (benzo[d][1,3]dioxol-5-yl)(4-(4-fluorophenyl)piperazin-1-yl)methanone.
5 . The method according to claim 3 , wherein the cell is in vitro.
6 . The method according to claim 3 , wherein the cell is in vivo.
7 . The method according to claim 6 further comprising:
administering the compound to a subject under conditions effective to cause the compound to contact the cell.
8 . A composition comprising a compound according to claim 1 and a carrier.
9 . The composition according to claim 8 , wherein the carrier is selected from the group of lotion, gel, solution, or aerosol.
10 . The composition according to claim 8 in the form of a sunless tanning lotion.
11 . A method of increasing skin pigmentation, said method comprising:
applying a composition according to claim 8 to skin on a subject in a manner and quantity effective to induce melanin production in contacted skin cells, thereby increasing skin pigmentation within a treated area of the skin.
12 . The method according to claim 11 , wherein the compound is selected from the group of N-(4-fluorophenethyl)-2-ethylquinoline-3-carboxamide; N-(3-fluorophenethyl)-2-ethylquinoline-3-carboxamide; N-((furan-2-yl)methyl)furan-2-carboxamide; N-butylfuran-2-carboxamide; N-(4-fluorophenethyl)furan-2-carboxamide; N-(3-fluorophenethyl)furan-2-carboxamide; (furan-2-yl)(2,2,6,6-tetramethylpiperidin-1-yl)methanone; (2,2,6,6-tetramethylpiperidin-1-yl)(perfluorophenyl)methanone; 2,3,4,5,6-pentafluoro-N-(5-methylisoxazol-3-yl)benzamide; and (benzo [d][1,3]dioxol-5-yl)(4-(4-fluorophenyl)piperazin-1-ylmethanone.
13 .- 20 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.